A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis-Reference-Cited by-同舟云学术

A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis

Published:2014-12 Issue:6 Volume:71 Page:1176-1182
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Gordon Kenneth B.,Leonardi Craig L.,Lebwohl Mark,Blauvelt Andrew,Cameron Gregory S.,Braun Daniel,Erickson Janelle,Heffernan Michael

Publisher

Elsevier BV

Subject

Dermatology

Reference9 articles.

1. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells;Lowes;J Invest Dermatol,2008

2. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis;Chiricozzi;J Invest Dermatol,2011

3. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A;Rizzo;J Immunol,2011

4. Circulating Th17, Th22, and Th1 cells are increased in psoriasis;Kagami;J Invest Dermatol,2010

5. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis;Krueger;J Allergy Clin Immunol,2012

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term risk and long-term incidence rate of infection and malignancy with IL-17 and IL-23 inhibitors in adult patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis;Frontiers in Immunology;2023-11-29

2. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium;Immunotherapy;2023-10

3. The roles of lncRNAs in Th17-associated diseases, with special focus on JAK/STAT signaling pathway;Clinical and Experimental Medicine;2023-09-24

4. Unleashing the Power of IL-17: A Promising Frontier in Chronic Obstructive Pulmonary Disease (COPD) Treatment;Cureus;2023-07-16

5. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12